Borviz Injection

The Borviz Injection is used for the treatment of multiple myeloma. With complete help and support of our team members, we deliver high grade and excellent range that commensurate to globally accepted standards. Thanks to our immense expertise of the domain, we as a Supplier, strives to deliver nothing short of excellence to our customers. Details : Borviz contains Bortezomib which is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma.